Iaconelli, Antonio
Cuthbert, Joe
Kazmi, Syed
Maffia, Pasquale
Clark, Andrew L.
Cleland, John G. F.
Pellicori, Pierpaolo http://orcid.org/0000-0001-7175-0464
Article History
Received: 12 December 2022
Accepted: 22 February 2023
First Online: 10 March 2023
Declarations
:
: Dr. Pellicori has received consultancy honoraria and/or sponsorship support from Boehringer Ingelheim, Pharmacosmos, Novartis, Vifor, AstraZeneca and Caption Health and research support from Bristol Myers Squibb in the past 5 years, not connected with this manuscript. Dr. Cleland reports grants from British Heart Foundation; personal fees from Abbott, personal fees from Amgen, grants and personal fees from Bayer, grants and personal fees from Bristol Myers Squibb, personal fees from Novartis, personal fees from Medtronic, personal fees from Idorsia, grants and personal fees from Vifor, personal fees from Servier, personal fees and non-financial support from Boehringer-Ingelheim, personal fees from Astra-Zeneca, personal fees from Innolife, personal fees from Torrent, grants and personal fees from Johnson & Johnson, grants and personal fees from Myokardia, personal fees from Respicardia, grants and personal fees from Viscardia, personal fees and non-financial support from NI Medical, grants from Pharma Nord, grants from Pharmacosmos. Others do not have any conflicts of interest to declare.